|
|
Article: Aspirin-exacerbated respiratory disease patients can take new COX-2 versions.
- Article from:
- Respiratory Therapeutics Week
- Article date:
- June 30, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 JUN 30 - (NewsRx.com & NewsRx.net) -- Aspirin-exacerbated respiratory disease patients can consider taking the new, highly selective COX-2 inhibitors.
"Aspirin and nonsteroidal antiinflammatory drugs (NSAIDs) exert their clinical effect through inhibition of prostaglandin H synthases 1 and 2, also known as cyclooxygenase. This shared effect of COX-inhibition is also the mechanism for shared adverse effects. Much of our understanding of crossreacting drugs and chemicals with aspirin comes from studying asthmatics with aspirin exacerbated respiratory disease (AERD)," scientists in the United States report.
"Aspirin exacerbated respiratory disease is ...